- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
International Isotopes inks deals
Nuclear medicine start-up International Isotopes of Denton, TX, has formed alliances with several universities and institutions as part of the company's plan to develop a U.S. source for radioisotopes used for medical purposes (SCAN 9/3/97). The firm
Nuclear medicine start-up International Isotopes of Denton, TX, has formed alliances with several universities and institutions as part of the company's plan to develop a U.S. source for radioisotopes used for medical purposes (SCAN 9/3/97). The firm inked relationships with the University of Texas M.D. Anderson Health Sciences Center, the University of North Texas, the University of California's Lawrence Berkeley Laboratory, and Texas A&M University. The agreements will help International Isotopes develop linear accelerator technology to produce radiopharmaceuticals.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
